Twist Bioscience Corp financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
TWST on Nasdaq
Location
South San Francisco, CA
Fiscal year end
30 September
Latest financial report
26 Feb 2026

Latest SEC snapshot (2026-01-27) highlights Return On Equity -16.8%, Return On Assets -12.3%, and Current Ratio 3.78x.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

47.4/100

Caution Confidence medium

Return On Equity

-17%

Metric score 0.0/100

Return On Assets

-12%

Metric score 0.0/100

Financial Health

Current Ratio
3.78x
Quick Ratio
2.47x
Debt to Equity
0.36x

Strengths

Debt-to-equity and NetIncomeLoss YoY

Watchpoints

Return On Equity and Return On Assets

Key metrics snapshot

Return On Equity

-17%

YoY: -55%

Industry median: -47% (n=217)

View history

Return On Assets

-12%

YoY: -58%

Industry median: -45% (n=216)

View history

Current Ratio

3.78x

YoY: -24%

Industry median: 3.67x (n=218)

View history

Quick Ratio

2.47x

YoY: -34%

Industry median: 2.63x (n=83)

View history

Debt-to-equity

0.36x

YoY: +23%

Industry median: 0.28x (n=202)

View history

NetIncomeLoss YoY

61%

YoY:

Industry median: -9.9% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -17% -55%
Return On Assets -12% -58%

Financial Health

Metric Latest value YoY change
Current Ratio 3.78x -24%
Quick Ratio 2.47x -34%
Debt-to-equity 0.36x +23%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY 61%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 61,311,704 +2.8%
Common Stock, Shares, Outstanding 61,274,000 +2.8%
Common Stock, Value, Issued $0
Weighted Average Number of Shares Outstanding, Basic 61,080,000 +3.2%
Weighted Average Number of Shares Outstanding, Diluted 61,080,000 +3.2%

Additional Metrics

Metric Latest value YoY change
Cost of Revenue $189,423,000 +3.5%
Research and Development Expense $76,108,000 -15%
Costs and Expenses $526,072,000 -2.3%
Operating Income (Loss) $134,515,000 +35%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $75,708,000 +62%
Income Tax Expense (Benefit) $875,000 +63%
Earnings Per Share, Basic -1.27 +62%
Earnings Per Share, Diluted -1.27 +62%
Cash and Cash Equivalents, at Carrying Value $148,591,000 -33%
Accounts Receivable, after Allowance for Credit Loss, Current $50,062,000 +27%
Inventory, Net $32,924,000 +40%
Assets, Current $303,882,000 -12%
Property, Plant and Equipment, Net $105,119,000 +4.4%
Operating Lease, Right-of-Use Asset $72,266,000 +28%
Goodwill $82,195,000 -4.2%
Other Assets, Noncurrent $4,730,000 +37%
Assets $638,085,000 +4.8%
Accounts Payable, Current $12,493,000 +67%
Employee-related Liabilities, Current $18,835,000 -13%
Accrued Liabilities, Current $23,405,000 +16%
Liabilities, Current $80,441,000 +16%
Operating Lease, Liability, Noncurrent $85,808,000 +27%
Other Liabilities, Noncurrent $741,000 +82%
Liabilities $181,990,000 +19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $571,000 +12%
Retained Earnings (Accumulated Deficit) $1,350,085,000 -6%
Stockholders' Equity Attributable to Parent $456,095,000 +0.03%
Liabilities and Equity $638,085,000 +4.8%
Other Noncash Income (Expense) $336,000 +1580%
Increase (Decrease) in Accounts Receivable $6,826,000 -250%
Share-based Payment Arrangement, Noncash Expense $13,273,000 +11%
Net Cash Provided by (Used in) Operating Activities $24,814,000 -16%
Net Cash Provided by (Used in) Financing Activities $298,000 -98%
Net Cash Provided by (Used in) Investing Activities $9,933,000 -547%
Common Stock, Shares Authorized 200,000,000 +100%
Common Stock, Shares, Issued 61,274,000 +2.8%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $34,440,000 -579%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $150,985,000 -33%
Operating Lease, Liability $98,050,000 +19%
Depreciation $23,600,000 -11%
Payments to Acquire Property, Plant, and Equipment $9,974,000 +340%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $76,505,000 +61%
Lessee, Operating Lease, Liability, to be Paid $155,003,000 +19%
Property, Plant and Equipment, Gross $205,285,000 +13%
Operating Lease, Liability, Current $12,242,000 -19%
Lessee, Operating Lease, Liability, to be Paid, Year Two $12,572,000 +50%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,450,000 -39%
Operating Lease, Weighted Average Discount Rate, Percent 0.069 +6.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $56,953,000 +20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,793,000 +27%
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,096,000 +68%
Operating Lease, Payments $3,885,000 +5%
Additional Paid in Capital $1,806,751,000 +4.4%
Amortization of Intangible Assets $1,100,000 -65%
Depreciation, Depletion and Amortization $6,194,000 -2.9%
Share-based Payment Arrangement, Expense $65,741,000 +27%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%